The buzz at the Drug Information Association’s (DIA) annual meeting — being held in person this week in Chicago after two “virtual” years — is focused largely on user fee reauthorization as a legislative package makes its way through the Senate following the passage of a House version on June 8.
Source: Drug Industry Daily